Anixa Biosciences
ANIX
ANIX
60 hedge funds and large institutions have $13.1M invested in Anixa Biosciences in 2026 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
26% less capital invested
Capital invested by funds: $17.8M → $13.1M (-$4.63M)
44% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 16
Holders
60
Holding in Top 10
–
Calls
$297K
Puts
$5K
Top Buyers
| 1 | +$393K | |
| 2 | +$274K | |
| 3 | +$88.8K | |
| 4 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$74K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$49.5K |
Top Sellers
| 1 | -$646K | |
| 2 | -$452K | |
| 3 | -$355K | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$293K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$186K |
